Epicore Biosystems secures an additional $6M in Series B funding for expanding its sweat-sensing wearables.The total Series B raise for the company now stands at $32M, with support from new and existing investors.The investment will accelerate global expansion efforts and the development of next-generation sweat-sensing technologies.Epicore's wearables track various physiological markers in real-time and have diverse applications in industrial, athletic, and clinical settings.